A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abstract
Hereditary haemochromatosis (HH), which affects some 1 in 400 and has an estimated carrier frequency of 1 in 10 individuals of Northern European descent, results in multi-organ dysfunction caused by increased iron deposition, and is treatable if detected early. Using linkage-disequilibrium and full haplotype analysis, we have identified a 250-kilobase region more than 3 megabases telomeric of the major histocompatibility complex (MHC) that is identical-by-descent in 85% of patient chromosomes. Within this region, we have identified a gene related to the MHC class I family, termed HLA-H, containing two missense alterations. One of these is predicted to inactivate this class of proteins and was found homozygous in 83% of 178 patients. A role of this gene in haemochromatosis is supported by the frequency and nature of the major mutation and prior studies implicating MHC class I-like proteins in iron metabolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HFE encodes an atypical MHC class I molecule which plays a major role in the regulation of iron homeostasis under basal conditions (Feder et al., 1996; Ludwiczek et al., 2004).”
From Genetic and Dietary Iron Overload Differentially Affect the Course of Salmonella Typhimurium Infection (2017) · cites this paper as Feder et al., 1996
In the citing paper
“Two decades later that insight led to the identification of HFE (originally called HLA-H), the gene mutated in the large majority of patients with hemochromatosis.121”
From Forging a field: the golden age of iron biology. (2008) · cites this paper as [121]
In the citing paper
“This mutation disrupts the formation of the disulfide bridge, which appears to be necessary for proper protein formation, causing the aberrant protein remains in the Golgi (24, 83).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [83]
In the citing paper
“Normal HFE protein associates with TfR, usually in conjunction with β2-microglobulin, and competes with Tf for TfR binding, thereby inhibiting Fe-Tf uptake via the TfR in cells (83, 179).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [83]
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Structure of the human class I histocompatibility antigen, HLA-A2
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329506a0 · Cited by 3,472
Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.
Weber, J. L., & May, P. E. (1989) · Europe PMC (PubMed Central) · Cited by 3,399
A comprehensive genetic map of the human genome based on 5,264 microsatellites
Dib, C., Fauré, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Kazan, J., Seboun, E., et al. (1996) · Nature · doi:10.1038/380152a0 · Cited by 2,928
Shizuya, H., Birren, B., Kim, U. J., Mancino, V, Slepak, T., Tachiiri, Y., & Simon, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8794 · Cited by 1,671
β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells
Zijlstra, M., Bix, M., Simister, N. E., Loring, J. M., Raulet, D. H., & Jaenisch, R. (1990) · Nature · doi:10.1038/344742a0 · Cited by 1,012
Current Protocols in Human Genetics
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471142905 · Cited by 987
Normal Development of Mice Deficient in β 2 M, MCClass I Proteins, and CD8 + T Cells
Koller, B. H., Marrack, P., Kappler, J. W., & Smithies, O. (1990) · Science · doi:10.1126/science.2112266 · Cited by 881
A new bacteriophage P1–derived vector for the propagation of large human DNA fragments
loannou, P. A., Amemiya, C. T., Garnes, J., Kroisel, P. M., Shizuya, H., Chen, C., Batzer, M. A., & de Jong, P. J. (1994) · Nature Genetics · doi:10.1038/ng0194-84 · Cited by 844
Research works printed but not linked: 1
- Hudson, T. et al. An STS-based map of the human genome. Science 270, 1945–1954, with supplementary data from the Whitehead Institute/MIT Center for Genome Research, human genetic mapping project, data release 10(May 1996) (1995). · DOI · Paper page
Cited by
Items 801–900 of 1,020
Zhao, N., Zhang, A.-S., Worthen, C., Knutson, M. D., & Enns, C. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405355111 · Cited by 64
“Moreover, HFE expression decreases the stability of ZIP14, suggesting the involvement of protein degradation and intracellular iron in ZIP14 regulation.”
BackgroundInfluentialMorán‐Jiménez, M., Fontanellas, A., Brudieux, E., Hombrados, I., de Lédinghen, V., Couzigou, P., de Verneuil, H., & de Salamanca, R. E. (1998) · Hepatology · doi:10.1002/hep.510270237 · Cited by 66
“Hepatic porphyrins (pmol/mg protein) 54* (13-414) 597*,† (71-1923) 20 (7-23)”
InfluentialThe bone morphogenetic protein–hepcidin axis as a therapeutic target in inflammatory bowel disease
Wang, L., Trebicka, E., Fu, Y., Ellenbogen, S., Hong, C. C., Babitt, J. L., Lin, H. Y., & Cherayil, B. J. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21675 · Cited by 64
“Mutations in the HFE gene are associated with the most common inherited iron overload disorder in humans, type I hereditary hemochromatosis.(5,8) Recent work has shown that hepcidin transcription depends on functional interactions between signals induced by HFE and those activated by bone morphogenetic proteins (BMPs)…”
BackgroundNon-viral factors contributing to hepatocellular carcinoma
Hamed, M. A. A., & Ali, S. A. (2013) · World Journal of Hepatology · doi:10.4254/wjh.v5.i6.311 · Cited by 77
Brown, K. E., Kinter, M. T., Oberley, T. D., Freeman, M. L., Frierson, H. F., Ridnour, L. A., Tao, Y., Oberley, L. W., & Spitz, D. R. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00284-0 · Cited by 66
George, D. K., Ramm, G. A., Walker, N. I., Powell, L. W., & Crawford, D. H. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80162-7 · Cited by 67
Bartfay, W. J., & Bartfay, E. (2000) · Biological Research For Nursing · doi:10.1177/109980040000200106 · Cited by 67
Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patients
Vlierberghe, H. V., Langlois, M. R., Delanghe, J., Horsmans, Y., Michielsen, P. P., Henrion, J., Cartuyvels, R., Billiet, J., Vos, M. D., & Leroux-Roels, G. G. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00203-3 · Cited by 68
Cassanelli, S., Pignatti, E., Montosi, G., Garuti, C., Mariano, M., Campioli, D., Carbonieri, A., Baldini, E., & Pietrangelo, A. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00035-6 · Cited by 70
“The majority of the HC patients (83±100% in the different series) had the same mutation, changing cysteine at position 282 to tyrosine (C282Y) in the HFE protein [2].”
BackgroundMethodInfluentialDistinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation
Constante, M., Jiang, W., Wang, D., Raymond, V.-A., Bilodeau, M., & Santos, M. M. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00092.2006 · Cited by 65
“The gene associated with HH type 1 has been identified as HFE, coding for a major histocompatibility complex class I (MHC-I)-like molecule (11).”
BackgroundCell surface expression of HFE protein in epithelial cells, macrophages, and monocytes.
Parkkila, S., Parkkila, A. K., Waheed, A., Britton, R. S., Xy, Z., Fleming, R. E., Tomatsu, S., Br, B., & Sly, W. S. (2000) · PubMed · Cited by 70
Ben-Arieh, S. V., Zimerman, B., Smorodinsky, N. I., Yaacubovicz, M., Schechter, C., Bacik, I., Gibbs, J., Bennink, J. R., Yewdell, J. W., Coligan, J. E., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.21.10557-10562.2001 · Cited by 67
Smith, A. G., Clothier, B., Robinson, S., Scullion, M. J., Carthew, P., Edwards, R., Luo, J., Lim, C. K., & Toledano, M. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.1.52 · Cited by 65
“…that the sporadic nature of nonfamilial PCT might be explained by predisposed individuals being carriers of the hemochromatosis C28Y mutation (Roberts et al., 1997) that has been identified recently, although its function with respect to iron metabolism is not understood (Feder et al., 1996).”
BackgroundCurrent applications of therapeutic phlebotomy.
(2014) · Europe PMC (PubMed Central) · doi:10.2450/2013.0299-12 · Cited by 65
Insights into the Pathogenesis and Treatment of Cancer from Inborn Errors of Metabolism
Erez, A., Shchelochkov, O. A., Plon, S. E., Scaglia, F., & Lee, B. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.03.005 · Cited by 67
“HFE-related hereditary hemochromatosis is an inborn error of iron metabolism caused by mutations in HFE-encoding (MIM 613609) hereditary hemochromatosis protein.(38,39) The gene product binds to the transferrin receptor and reduces its affinity for iron-loaded transferrin.”
BackgroundHereditary Hemochromatosis Restores the Virulence of Plague Vaccine Strains
Quenee, L. E., Hermanas, T. M., Ciletti, N., Louvel, H., Miller, N. C., Elli, D., Blaylock, B., Mitchell, A., Schroeder, J., Krausz, T., et al. (2012) · Journal of Infectious Diseases · doi:10.1093/infdis/jis433 · Cited by 65
“Because HFE C282Y is associated with decreased iron levels in macrophages, the hypothesis by Moalem and colleagues predicts that, at least early in life, immune cells of individuals with hereditary hemochromatosis may gain the advantage of improved clearance for bacterial pathogens.”
BackgroundInfluentialDiagnosis and therapy of genetic haemochromatosis (review and 2017 update)
Fitzsimons, E. J., Cullis, J., Thomas, W., Tsochatzis, E. A., Griffiths, W. J., & the British Society for Haematology (2018) · British Journal of Haematology · doi:10.1111/bjh.15164 · Cited by 74
Self-citationDuseja, A. K., Das, R., Nanda, M., Das, A., Garewal, G., & Chawla, Y. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i3.393 · Cited by 66
Recently Identified Molecular Aspects of Intestinal Iron Absorption
Wood, R. J., & Han, O. (1998) · Journal of Nutrition · doi:10.1093/jn/128.11.1841 · Cited by 72
Iron Pathophysiology in Alzheimer’s Diseases
Wang, T., Xu, S.-F., Fan, Y.-G., Li, L.-B., & Guo, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_5 · Cited by 64
Whole-Genome Sequencing: The New Standard of Care?
Brunham, L. R., & Hayden, M. R. (2012) · Science · doi:10.1126/science.1220967 · Cited by 71
Hereditary hemochromatosis: update for 2003
Harrison, S. A., & Bacon, B. R. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00428-2 · Cited by 68
“In the initial study published in 1996, two missense mutations were identified in HFE [4].”
BackgroundInfluentialSelf-citationIron transport & homeostasis mechanisms: their role in health & disease.
Nadadur, S. S., Srirama, K., & Mudipalli, A. (2008) · PubMed · Cited by 96
Kawabata, H. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2365-3 · Cited by 68
Genetic iron overload disorders
Corradini, E., Buzzetti, E., & Pietrangelo, A. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100896 · Cited by 69
Prevalence and Penetrance of HFE Mutations in 4865 Unselected Primary Care Patients
Phatak, P. D., Ryan, D. H., Cappuccio, J. D., Oakes, D., Braggins, C., Provenzano, K., Eberly, S. W., & Sham, R. L. (2002) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2002.0536 · Cited by 67
Martinelli, A. L. C., Filho, A. B., Franco, R. F., Tavella, M. H., Ramalho, L. N. Z., Zucoloto, S., Rodrigues, S., & ZAGO, M. A. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03410.x · Cited by 64
Cenarro, A., Jensen, H. K., Casao, E., Civeira, F., González‐Bonillo, J., Rodríguez-Rey, J. C., Gregersen, N., & Pocoví, M. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:5<395::aid-humu7>3.0.co;2-4 · Cited by 32
Recalcati, S., Pometta, R., Levi, S., Conte, D., & Cairo, G. (1998) · Blood · doi:10.1182/blood.v91.7.2565 · Cited by 65
Hereditary Hemochromatosis: HFE Mutation Analysis in Greeks Reveals Genetic Heterogeneity
Papanikolaou, G. V., Politou, M., Terpos, E., Fourlemadis, S., Sakellaropoulos, N., & Loukopoulos, D. (2000) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2000.0292 · Cited by 73
Signal transduction and transcription factors in rheumatic disease
Firestein, G. S., & Manning, A. M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:4<609::aid-anr3>3.0.co;2-i · Cited by 198
Phenotype-genotype correlation in haemochromatosis subjects
Mura, C., Nousbaum, J., Verger, P., Moalic, M.-T. X. E. R. X. E. S., Raguénès, O., Mercier, A., & Férec, C. (1997) · Human Genetics · doi:10.1007/s004390050628 · Cited by 66
A Method for Detecting Recent Selection in the Human Genome From Allele Age Estimates
Toomajian, C., Ajioka, R. S., Jorde, L. B., Kushner, J. P., & Kreitman, M. (2003) · Genetics · doi:10.1093/genetics/165.1.287 · Cited by 65
Iron regulates glucose homeostasis in liver and muscle via AMP‐activated protein kinase in mice
Huang, J., Simcox, J., Mitchell, T. C., Jones, D., Cox, J. E., Luo, B., Cooksey, R. C., Boros, L. G., & McClain, D. A. (2013) · The FASEB Journal · doi:10.1096/fj.12-216929 · Cited by 67
Abraham, D., Rogers, J., Gault, P. M., Kushner, J. P., & McClain, D. A. (2006) · Diabetologia · doi:10.1007/s00125-006-0445-7 · Cited by 63
“HFE genotyping was performed using allele-specific PCR primers as previously described [8].”
BackgroundInfluentialEffects of a ginger extract on knee pain in patients with osteoarthritis
Altman, R. D., & Marcussen, K. C. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200111)44:11<2531::aid-art433>3.0.co;2-j · Cited by 507
McCune, C. A., Ravine, D., Carter, K., Jackson, H. A., Hutton, D., Hedderich, J., Krawczak, M., & Worwood, M. (2005) · Gut · doi:10.1136/gut.2005.070342 · Cited by 65
Bodmer, J. G., Parham, P., Albert, E. D., & Marsh, S. G. E. (1997) · Nature Genetics · doi:10.1038/ng0397-234c · Cited by 63
Investigation of a Researcher's Death Due to Septicemic Plague
Frank, K. M., Schneewind, O., & Shieh, W.-J. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1010939 · Cited by 62
Molecular pathogenesis of human hepatocellular carcinoma
Kern, M. A., Breuhahn, K., & Schirmacher, P. (2002) · Advances in cancer research · doi:10.1016/s0065-230x(02)86003-1 · Cited by 68
Henker, R., Lewis, A., Dai, F., Lariviere, W. R., Li, M., Gruen, G. S., Sereika, S. M., Pape, H., Tarkin, I. S., Gowda, I., et al. (2012) · Biological Research For Nursing · doi:10.1177/1099800411436171 · Cited by 62
“Therefore, it is highly possible that the uniqueness of our patient population (or cases in other finemapping studies; Feder et al., 1996; Jiang et al., 2001) resulted in the HWD of these two COMT SNPs.”
BackgroundHarrison, S. A., & Bacon, B. R. (2005) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.08.005 · Cited by 67
Self-citationBibliometric analysis of the top-cited gastroenterology and hepatology articles
Azer, S. A., & Azer, S. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009889 · Cited by 66
Functional and molecular responses of human intestinal Caco-2 cells to iron treatment
Tallkvist, J., Bowlus, C. L., & Lönnerdal, B. L. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.3.770 · Cited by 71
Relationships and distinctions in iron-regulatory networks responding to interrelated signals
Muckenthaler, M., Richter, A., Gunkel, N., Riedel, D., Polycarpou-Schwarz, M., Hentze, S., Falkenhahn, M., Stremmel, W., Ansorge, W., & Hentze, M. W. (2003) · Blood · doi:10.1182/blood-2002-07-2140 · Cited by 63
Hepcidin: an important new regulator of iron homeostasis
Hugman, A. (2006) · Clinical & Laboratory Haematology · doi:10.1111/j.1365-2257.2006.00768.x · Cited by 76
High-dose Vitamin C: A Risk for Persons with High Iron Stores?
Gerster (1999) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831.69.2.67 · Cited by 62
“The genetic defect associated with hereditary hemochromatosis has recently been identified and the locus has been linked to the HLA-A class I region of the human major histocompatibility complex located on the short arm of chromosome 6 [10].”
BackgroundLio, D., Balistreri, C. R., Colonna‐Romano, G., Motta, M., Franceschi, C., Malaguarnera, M., Candore, G., & Caruso, C. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363823 · Cited by 65
Mutations of the HFE gene in patients with hepatocellular carcinoma
Cauza, E., Peck-Radosavljevic, M., Ulrich-Pur, H., Datz, C., Gschwantler, M., Schoniger-Hekele, M., Hackl, F., Polli, C., Rasoul-Rockenschaub, S., Muller, C., et al. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05890-2 · Cited by 69
“Two missense mutations (C282Y and H63D) in the gene (“HFE”) are responsible for most cases of genetic hemochromatosis ( 13 ).”
BackgroundMutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload
Elder, G. H., & Worwood, M. (1998) · Hepatology · doi:10.1002/hep.510270142 · Cited by 67
Recent advances in understanding haemochromatosis: a transition state
Robson, K. J. H., Merryweather-Clarke, A. T., Cadet, E., Viprakasit, V, Zaahl, M. G., Pointon, J. J., Weatherall, D. J., & Rochette, J. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.020644 · Cited by 61
Duodenal expression of iron transport molecules in untreated haemochromatosis subjects
Stuart, K. A., Anderson, G. J., Frazer, D. M., Powell, L. W., McCullen, M., Fletcher, L. M., & Crawford, D. H. G. (2003) · Gut · doi:10.1136/gut.52.7.953 · Cited by 61
Sandhu, K., Flintoff, K., Chatfield, M. D., Dixon, J. L., Ramm, L. E., Ramm, G. A., Powell, L. W., Subramaniam, V. N., & Wallace, D. F. (2018) · Blood · doi:10.1182/blood-2018-02-830562 · Cited by 61
Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy
Kallianpur, A. R., Hulgan, T., Canter, J. A., Ritchie, M. D., Haines, J. L., Robbins, G. K., Shafer, R. W., Clifford, D. B., & Haas, D. W. (2006) · AIDS · doi:10.1097/01.aids.0000237366.56864.3c · Cited by 61
“Most cases are due to homozygosity for a missense mutation (a G-to-A transition at nucleotide 845, resulting in substitution of a tyrosine for a cysteine residue at position 282, or C282Y) in the HFE gene on chromosome 6p [22].”
BackgroundDarshan, D., Frazer, D. M., Wilkins, S. J., & Anderson, G. J. (2010) · Haematologica · doi:10.3324/haematol.2010.022426 · Cited by 61
Tisato, V., Zuliani, G., Vigliano, M., Longo, G., Franchini, E., Secchiero, P., Zauli, G., Paraboschi, E. M., Singh, A. V., Serino, M. L., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193867 · Cited by 61
HJV gene mutations in European patients with juvenile hemochromatosis
Gehrke, S. G., Pietrangelo, A., Kascak, M., Braner, A., Eisold, M., Kulaksiz, H., Herrmann, T. R. W., Hebling, U., Bents, K., Gugler, R., et al. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2005.00413.x · Cited by 70
“Another frequent mutation in HFE has been identified at amino acid 63 (H63D mutation, C to G transition at nucleotide 187) (4).”
BackgroundHFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls
de Juan, M., Reta, A., Castiella, A., Pozueta, J., Prada, A. J., & Cuadrado, E. (2001) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200731 · Cited by 66
Bozzini, C., Girelli, D., Tinazzi, E., Olivieri, O., Stranieri, C., Bassi, A., Trabetti, E., Faccini, G., Pignatti, P. F., & Corrocher, R. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.4.622 · Cited by 61
Mcnamara, Macphail, Gordeuk, Hasstedt, & Rouault (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00917.x · Cited by 63
Mangasser-Stephan, K., Tag, C. G., Reiser, A., & Gressner, A. M. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.10.1875 · Cited by 61
Incidence of liver disease in people with HFE mutations: Table 1
Willis, G. A., Wimperis, J. Z., Lonsdale, R., Fellows, I. W., Watson, M. A., Skipper, L. M., & Jennings, B. A. (2000) · Gut · doi:10.1136/gut.46.3.401 · Cited by 61
“The discovery of two hereditary haemochromatosis associated mutations in the HFE (HLA-H) gene”
BackgroundLupus Susceptibility Genes on Human Chromosome 1
Tsao, B. R. (2000) · International Reviews of Immunology · doi:10.3109/08830180009055502 · Cited by 61
Griffiths, W. J., Cox, T. M., & Sly, W. S. (2001) · Gastroenterology · doi:10.1053/gast.2001.24050 · Cited by 62
Boige, V., Castéra, L., de Roux, N., Ganne‐Carrié, N., Ducot, B., Pelletier, G., Beaugrand, M., & Buffet, C. (2003) · Gut · doi:10.1136/gut.52.8.1178 · Cited by 61
Population Screening for Haemochromatosis: A Unifying Analysis of Published Intervention Trials
Bradley, L., Haddow, J. E., & Palomaki, G. E. (1996) · Journal of Medical Screening · doi:10.1177/096914139600300404 · Cited by 61
Guillaudeux, T., Janer, M., Wong, G. K., Spies, T. A., & Geraghty, D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9494 · Cited by 61
Population Screening for Hemochromatosis
Adams, P. C. (1999) · Hepatology · doi:10.1002/hep.510290425 · Cited by 64
Bassett, M. L., Leggett, B., Halliday, J. W., Webb, S. I., & Powell, L. W. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80357-1 · Cited by 63
Hereditary Hemochromatosis: Time for Targeted Screening
Phatak, P. D., Bonkovsky, H. L., & Kowdley, K. V. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-4-200808190-00009 · Cited by 66
“The identification of the HFE gene (5) has radically altered our understanding of the clinical spectrum of this disorder.”
BackgroundWard, L. D., Tu, H.-C., Quenneville, C. B., Tsour, S., Flynn-Carroll, A. O., Parker, M. M., Deaton, A. M., Haslett, P. A. J., Lotta, L. A., Verweij, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24563-1 · Cited by 59
Cheng, E. L., Cardle, I. I., Kacherovsky, N. A., Bansia, H., Wang, T., Zhou, Y., Raman, J., Yen, A., Gutierrez, D., Salipante, S. J., et al. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c05349 · Cited by 62
Hemochromatosis gene modifies course of hepatitis C viral infection
Pietrangelo, A. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00275-0 · Cited by 67
Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis
Hunt, J. R., & Zeng, H. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.4.924 · Cited by 64
“HFE C282Y and H63D mutations were ascertained by using a two-round polymerase chain reaction (PCR; semi-nested primers) approach (37, 38) and enzymatic digestion of the products similar to that in previous reports (2, 39).”
BackgroundMethodInfluentialWhittington, C., & Kowdley, K. V. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01371.x · Cited by 72
Genetic markers and their application in poultry breeding
Emara, M., & Kim, H. (2003) · Poultry Science · doi:10.1093/ps/82.6.952 · Cited by 60
“On another note, many SNP are randomly located in the human genome; however, some SNP are also clustered within certain genes (Feder et al., 1996).”
BackgroundIron overload in porphyria cutanea tarda.
Sampietro, M., Fiorelli, G., & Fargion, S. R. (1999) · PubMed · Cited by 72
Population screening for haemochromatosis
Adams, P. C. (2000) · Gut · doi:10.1136/gut.46.3.301 · Cited by 65
“Results of many studies from around the world have revealed that haemochromatosis is the most prevalent genetic disease in people of European descent. However, it continues to be regarded as an uncommon disease by many physicians and is not listed as a common cause of death. The gene for haemochromatosis was discovere…”
BackgroundDeng, H., Chen, W., & Recker, R. R. (2000) · The American Journal of Human Genetics · doi:10.1086/302804 · Cited by 61
“As in the original investigations of Feder et al. (1996) and Nielsen et al. (1998), random mating is assumed, and, thus, HW equilibrium holds in the population.”
BackgroundMethodInfluentialAguilar‐Martinez, P., Biron‐Andréani, C., Blanc, F., Masmejean, C., Jeanjean, P., Michel, H., & Schved, J. (1997) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1997.0143 · Cited by 63
“F igure 1. Schematic representation of the expression of the normal and mutated HLA H protein, hypothesized according to the model proposed by Feder et al. ( 1 ,10) and following our clinical observations.”
BackgroundMethodResultInfluentialCalculation and Use of the Hardy‐Weinberg Model in Association Studies
Ryckman, K., & Williams, S. M. (2008) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0118s57 · Cited by 59
“Most notably, Feder et al. (1996) used HW disequilibrium (HWD) to narrow down the locus for hereditary hemochromatosis (HH), an autosomal recessive disorder that affects iron metabolism (Feder et al., 1996).”
Hereditary hemochromatosis: patient experiences of the disease and phlebotomy treatment
Brissot, P., Ball, S., Rofail, D., Cannon, H., & Jin, V. W. (2011) · Transfusion · doi:10.1111/j.1537-2995.2010.02997.x · Cited by 59
“Hispanic/Latin American 3 (4) White/Caucasian (non-Hispanic) 55 (79) Other 1 (1) Ethnicity (France) White/Caucasian (Blanc/Europeen) 48 (96) Northern African (Afrique du Nord) 1 (2) Asian (Continent Asiatique) 1 (2)”
BackgroundDiagnostic value of transferrin
Szőke, D., & Panteghini, M. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.04.021 · Cited by 66
“First described in 1996, the most frequent genetic defect is a G→A mutation of the HFE gene, leading to a substitution of tyrosine for cysteine (C282Y) in HFE protein [34].”
BackgroundModulation of hepcidin to treat iron deregulation: potential clinical applications
Blanchette, N. L., Manz, D. H., Torti, F. M., & Torti, S. V. (2016) · Expert Review of Hematology · doi:10.1586/17474086.2016.1124757 · Cited by 59
“Mutations in TFR2 or HFE result in partial hepcidin insufficiency, leading to a less severe form of HH.[49,50] It is thought that increasing concentrations of holo-transferrin results in the transfer of HFE from TFR1 to TFR2, stabilizing TFR2 and subsequently activating the downstream SMAD pathway.”
BackgroundKoyama, C., Hayashi, H., Wakusawa, S., Ueno, T., Yano, M., Katano, Y., Goto, H., & Kidokoro, R. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.024 · Cited by 59
“In Caucasians of Northern Europe ancestry, the major mutation responsible for hemochromatosis is C282Y of the HFE gene [1].”
BackgroundHFE cross-talks with the MHC class I antigen presentation pathway
de Almeida, S. F., Fidalgo-Carvalho, I., Cardoso, C. S. D. F. L. P., Cordeiro, J. V., Azevedo, J. E., Neefjes, J., & de Sousa, M. A. B. (2005) · Blood · doi:10.1182/blood-2004-12-4640 · Cited by 67
“16 HFE is a 343-residue type I transmembrane glycoprotein homologous to MHC class I proteins that also interacts with 2-m.(17) However, despite the structural similarities with MHC class I molecules, HFE lacks a functional peptide-binding groove.”
BackgroundKoyama, C., Wakusawa, S., Hayashi, H., Suzuki, R., Yano, M., Yoshioka, K., Kozuru, M., Takayamam, Y., Okada, T., & Mabuchi, H. (2005) · PubMed · Cited by 62
Chapter 6 Iron Homeostasis and Erythropoiesis
Wrighting, D. M., & Andrews, N. C. (2008) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(07)00006-3 · Cited by 71
Implications of genotyping of spouses to limit investigation of children in genetic hemochromatosis
Adams, P. C. (1998) · Clinical Genetics · doi:10.1111/j.1399-0004.1998.tb02672.x · Cited by 60
“A second mutation (H63D) was reported in a minority of cases in the original report and in a significant proportion of the general population (5, 12).”
BackgroundHereditary haemochromatosis: diagnosis and management in the gene era
Olynyk, J. K. (1999) · Liver International · doi:10.1111/j.1478-3231.1999.tb00014.x · Cited by 65
Waalen, J., Felitti, V. J., Gelbart, T., Ho, N. J., & Beutler, E. (2002) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2002.0596 · Cited by 60
Clinical consequences of iron overload in hemochromatosis homozygotes
Ajioka, R. S., & Kushner, J. P. (2003) · Blood · doi:10.1182/blood-2002-11-3453 · Cited by 58
Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases
Hetet, G., Elbaz, A., Gariépy, J., Nicaud, V., Arveiler, D., Morrison, C. E., Kee, F., Evans, A., Simon, A. C., Amarenco, P., et al. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00829.x · Cited by 59
García‐Escobar, A., Lázaro-García, R., Goicolea-Ruigómez, J., González‐Casal, D., Fontenla, A., Soto, N., González‐Panizo, J., Datino, T., Pizarro, G., Moreno, R., et al. (2024) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-024-00662-0 · Cited by 64
Expression and Iron-Dependent Regulation of Succinate Receptor GPR91 in Retinal Pigment Epithelium
Gnana‐Prakasam, J. P., Ananth, S., Prasad, P. D., Zhang, M., Atherton, S. S., Martin, P. M., Smith, S. B., & Ganapathy, V. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6722 · Cited by 61
“A loss-of-function mutation (Cys2823Tyr282) in HFE is responsible for approximately 85% of cases of hemochromatosis.(5) The clinical features of the disease include cirrhosis, hepatocarcinoma, diabetes, cardiomyopathy, nephropathy, and pituitary dysfunction.”
BackgroundHereditary hemochromatosis: Mutations in genes involved in iron homeostasis in Brazilian patients
Santos, P. C. J. L., Cançado, R. D., Pereira, A. C., Schettert, I. T., Soares, R. A. G., Pagliusi, R. A., Hirata, R. D. C., Hirata, M. H., Teixeira, A. C., Figueiredo, M. S., et al. (2011) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2011.02.008 · Cited by 65
Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice
Sebastiani, G., & Pantopoulos, K. (2011) · Metallomics · doi:10.1039/c1mt00082a · Cited by 57
Wischhusen, J., Waschbisch, A., & Wiendl, H. (2007) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.07.005 · Cited by 62
Liver transplantation for hereditary hemochromatosis
Brandhagen, D. J. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.25359 · Cited by 59
Cazzola, M., Beguin, Y., Bergamaschi, G., Guarnone, R., Cerani, P., Barella, S., Cao, A., & Galanello, R. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01600.x · Cited by 58
Metadata
- Authors
- Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., Hinton, L. M., Jones, N. L., Kimmel, B. E., Kronmal, G. S., Lauer, P., Lee, V. K., Loeb, D. B., Mapa, F. A., McClelland, E., Meyer, N. C., Mintier, G. A., Moeller, N., Moore, T., Morikang, E., Prass, C. E., Quintana, L., Starnes, S. M., Schatzman, R. C., Brunke, K. J., Drayna, D. T., Risch, N. J., Bacon, B. R., & Wolff, R. K.
- Affiliations
- Stanford Medicine (US)
- Saint Louis University (US)
- ORCID
- Venue
- Nature Genetics
- Published
- 1996-08
- Volume
- 13
- Issue
- 4
- Pages
- 399-408
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2002605005
- Cited by
- 3,664
- References
- 78
- Citations by year
- 2026: 27 · 2025: 27 · 2024: 38 · 2023: 47 · 2022: 51 · 2021: 47 · 2020: 67 · 2019: 50 · 2018: 58 · 2017: 92 · 2016: 87 · 2015: 80 · 2014: 74 · 2013: 94 · 2012: 96
- FWCI
- 124.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- hereditary hemochromatosis, HLA-H, HLA-F, missense mutations, iron metabolism, iron accumulation, linkage disequilibrium, haplotype analysis, homozygosity, gene inactivation
- MeSH terms
- Hemochromatosis Protein, Alleles, Amino Acid Sequence, Base Sequence, Chromosomes, Human, Pair 6, Cloning, Molecular, Cysteine, Biological Evolution, Genes, MHC Class I, Genetic Markers, Haplotypes, Hemochromatosis, HLA Antigens, Humans, Major Histocompatibility Complex, Membrane Proteins, Molecular Sequence Data, RNA, Messenger, Histocompatibility Antigens Class I, Linkage Disequilibrium, Gene Expression, Sequence Alignment, Sequence Homology, Amino Acid, DNA Primers, Chromosomes, Artificial, Yeast
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.